Article Text
Abstract
Plasma exchange is a highly efficient technique to remove circulating autoantibodies and other humoral factors rapidly from the vascular compartment. It was the first effective acute treatment for peripheral disorders such as Guillain-Barré syndrome and myasthenia gravis before intravenous immunoglobulin became available. The recent recognition of rapidly progressive severe antibody-mediated central nervous system disorders, such as neuromyelitis optica spectrum disorders and anti-N-methyl-D-aspartate-receptor encephalitis, has renewed interest in using plasma exchange for their acute treatment also. In this review we explain the principles and technical aspects of plasma exchange, review its current indications, and discuss the implications for its provision in the UK.
- neuroimmunology
- evidence-based neurology
- clinical neurology
Statistics from Altmetric.com
Footnotes
Contributors CO wrote the draft manuscript. RJ and KE-G contributed to the practicalities of PLEX. AAP reviewed the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned. Externally peer reviewed by Marguerite Hill, Swansea, UK and Aisling Carr, London, UK
Read the full text or download the PDF:
Other content recommended for you
- Therapeutic plasma exchange (TPE) for semi-critical neurology presentations in a non-acute neurology set-up: clinical practice and challenges
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- Autologous haematopoietic stem cell transplantation for neurological diseases
- INFLAMMATORY/POST-INFECTIOUS ENCEPHALOMYELITIS
- Rhomboencephalitis
- Intravenous immunoglobulin in neurological disease: a specialist review
- Neuromyelitis optica spectrum disorder presenting in an octogenarian
- Treatment of CIDP
- A nationwide survey of combined central and peripheral demyelination in Japan
- Pathophysiology, diagnosis, and management of neuroinflammation in covid-19